Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
09/2007
09/12/2007CN101032554A Medicine for curing frequently encountered disease caused by Huohan toxicum and the preparing method
09/12/2007CN101032550A Medicine combination for curing diabetes and complication thereof and the preparing method and purpose
09/12/2007CN101032538A Method of preparing substances extracted from Gynura procumbens (Lour.) Merr. and the application
09/12/2007CN101032537A Gynura procumbens (Lour.) Merr. Flavonoid substances preparing method and the application
09/12/2007CN101032532A Medicine composition including active substrates extracted from Sang Huang, the preparing method and the application in the producing of medicine thereof
09/12/2007CN101032523A Royal jelly acid calcium and preparation process thereof
09/12/2007CN101032511A Health wine for conditioning blood sugar and the preparing method
09/12/2007CN101032490A External agent for losing weight
09/12/2007CN101032477A Electrolyte complementary medical combination for injection
09/12/2007CN101032473A Sandwich type medical releasing film and preparing method thereof
09/12/2007CN101032331A Health product for reducing blood sugar
09/12/2007CN101032330A Health product of reducing blood sugar
09/12/2007CN101032329A Health product for losing weight
09/12/2007CN101032328A Health product for losing weight
09/12/2007CN101032327A Health product for losing weight
09/12/2007CN101032326A Health product for losing weight
09/12/2007CN101032325A Anti-hypertensive health products
09/12/2007CN101032323A Functionality foods including ginger oil resin
09/12/2007CN101032294A Composited pre-mixed feed additives for prevention of sow constipation
09/12/2007CN101032271A Gingko coffee
09/12/2007CN101032270A Preparing method of composite type persimmon leaf tea
09/12/2007CN101032269A Compound bag-soak-tea
09/12/2007CN101032268A Pericarpium citri reticulatae Pu-erh tea
09/12/2007CN101032266A Teal oil including carotenoid and production method thereof
09/12/2007CN100336558C Method for preparing cow foremilk immune globulin microcapsulation
09/12/2007CN100336557C Somatostation a aqua prepn and its prepn process and application
09/12/2007CN100336528C Chinese medicinal preparation for treating high blood pressure and high blood fat
09/12/2007CN100336526C Medicine composition for treating diabetes and preparing method
09/12/2007CN100336522C Greater celandine extract herbal preparation for treating diabetes
09/12/2007CN100336521C Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity
09/12/2007CN100336517C Red rice and gingko leaf composition for preventing and treating cardiovascular and cerebrovascular disease and its application
09/12/2007CN100336512C Bambbo leaf flavone freeze dried powser injection, its preparation method and application
09/11/2007US7268213 Glucagon-like peptide-1 (glp-1) receptor agonist
09/11/2007US7268161 Using mixtur eof serotonin reuptake inhibitor, such as phenlemine, 5-hydroxytrophophan, Vitamin C, Vitamin B6, tyrosine, calcium
09/11/2007US7268157 Substituted arylalcanoic acid derivatives as PPAR pan agonists with potent antihyperglycemic and antihyperlipidemic activity
09/11/2007US7268152 Antiinflammatory agents; antiallergens; antiproliferative agents
09/11/2007US7268150 2-cyano-4-fluoropyrrolidine derivative or its salt
09/11/2007US7268146 (3,4-Dihydro-1H-isoquinolin-2-yl)-[2-methyl-7-(2,4,6-trimethyl-phenyl)-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-b]pyridin-3-yl]-methanone; Corticotropin releasing factor (CRF); stress-related illnesses, mood disorders such as depression, major depressive disorder, single episode depression
09/11/2007US7268141 Xanthine phosphodiesterase V inhibitors
09/11/2007US7268133 Cannabinoid receptor ligands and uses thereof
09/11/2007US7268125 2-(azetidin-2-on-1-yl)alkanedioic acid esters and amides useful for treating disease states that are associated with and responsive to antagonism of a vasopressin V1a receptor in a mammal
09/11/2007US7267813 Inhalation particles incorporating a combination of two or more active ingredients
09/11/2007CA2383355C Vitamin b solution with reduced bitterness
09/11/2007CA2372720C Androgen glycosides and androgenic activity thereof
09/11/2007CA2193967C Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
09/11/2007CA2151381C Recombinant dog gastric lipase and pharmaceutical compositions
09/07/2007WO2007100880A1 Cinnoline and quinazoline derivates as phosphodiesterase 10 inhibitors
09/07/2007WO2007100822A2 Fluvastatin sodium pharmaceutical compositions
09/07/2007WO2007100566A2 Use of dha and ara in the preparation of a composition for regulating gene expression
09/07/2007WO2007100562A2 Use of dha and ara in the preparation of a composition for reducing triglyceride levels
09/07/2007WO2007100561A2 Use of dha and ara in the preparation of a composition for preventing or treating obesity
09/07/2007WO2007100104A1 Anorexigenic agent
09/07/2007WO2007100103A1 Ameliorating agent for metabolic syndrome
09/07/2007WO2007100098A1 Multimer of extracellular domain of cell surface functional molecule
09/07/2007WO2007100027A1 Optically active thiazolidinedione derivative
09/07/2007WO2007099345A1 Medical use of bmp-2 and/ or bmp-4
09/07/2007WO2007098939A1 Use of compounds binding to the sigma receptor for the treatment of metabolic syndrome
09/07/2007WO2007098681A1 Use of a monoterpene in manufacturing medicaments for treating diabetes mellitus
09/07/2007WO2007098680A1 The uses of d-limonene, plant or valatile oil thereof containing d-limonene in manufacturing medicaments for preventing and treating diabetes
09/07/2007WO2007098644A1 Benzopyran compounds and their preparation method and their usage
09/07/2007WO2007084290A3 Compositions of an anticonvulsant and psychotherapeutic and methods of using the same for reversing weight gain
09/07/2007WO2007079914A3 Combination of triazine derivatives and insulin secretion stimulators
09/07/2007WO2007079317A3 Use of sedative hypnotics for treating obesity or maintaining weight loss
09/07/2007WO2007057849A3 2,3,4,5-tetrahydroxy-6-sulfooxyhexanoic acid and its metal salts for medical use
09/07/2007WO2007023172A3 Protein composition for treating a physiologically caused, clinically normal increased need for protein
09/07/2007WO2006124544A3 Use of tyrosine kinase inhibitors in the treatment of metabolic disorders
09/07/2007CA2645123A1 Use of dha and ara in the preparation of a composition for regulating gene expression
09/07/2007CA2644046A1 Metabolic regulators and uses thereof
09/07/2007CA2643044A1 Cinnoline and quinazoline derivates as phosphodiesterase 10 inhibitors
09/07/2007CA2642969A1 Method for increasing lean musclse mass and decreasing adipose tissue
09/07/2007CA2642195A1 Fluvastatin sodium pharmaceutical compositions
09/07/2007CA2640754A1 Pyrazole derivatives as sigma receptors antagonists
09/07/2007CA2638869A1 Humanized anti-ghrelin antibodies
09/07/2007CA2635280A1 Side chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
09/06/2007US20070208179 Novel diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
09/06/2007US20070208077 Adiponectin Enhancer
09/06/2007US20070208048 New Aryl Imidazoles and Related Compounds as C5a Receptor Modulators
09/06/2007US20070208046 such as 4-benzyloxy-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1H-pyridin-2-one, that as antagonists to melanin concentrating hormone receptors, used for treating cardiovascular, nervous system, metabolic, reproductive system, respiratory system and gatrointestinal disorders
09/06/2007US20070208036 Arylalkanes, arylalkenes and aryl-azaalkanes, pharmaceutical compositions containing these compounds and processes for preparing them
09/06/2007US20070208032 Chemical compounds
09/06/2007US20070208026 N-Containing Heteroaromatic Compounds As Modulators Of Ppars And Methods Of Treating Metabolic Disorders
09/06/2007US20070208021 Phenoxyacetic Acid Derivatives and Drug Comprising The Same
09/06/2007US20070208008 Substituted sulfonamides and ureas useful for inhibiting kinase activity
09/06/2007US20070207983 Use of Sphingolipids in the Treatment and Prevention of Type 2 Diabetes Mellitus, Insulin Resistance and Metabolic Syndrome
09/06/2007US20070207964 Combined use of a GLP-1 compound and another drug for treating dyslipidemia
09/06/2007US20070207957 Composition For Accelerating Alcohol Metabolism Or Relieving Fatigue By Gluconeogenesis
09/06/2007US20070207229 Inhibitor of blood glucose level elevation and inhibitor of age generation comprising acerola leaf extract and food product comprising either thereof
09/06/2007US20070207214 Oral pharmaceutical compositions with controlled release and prolonged absorption
09/06/2007US20070207148 Genes associated with obesity and methods for using the same
09/06/2007US20070207136 Food and vitamin preparations containing the natural isomer of reduced folates
09/06/2007DE102006009813A1 Verwendung von A2b/A1 Rezeptor Agonisten zur Modulation der Lipidspiegel Use of A2b / A1 receptor agonists to modulate lipid levels
09/05/2007EP1829881A1 Combination of rapamycin and its tetrazole isomers and epimers, methods of making and using the same
09/05/2007EP1829877A1 Bicyclic pyrrole derivatives
09/05/2007EP1829876A1 Nitrogeneous tricyclic compound
09/05/2007EP1829873A1 Pyrrazole derivatives as sigma receptors antagonists
09/05/2007EP1829863A1 Arylalkanoic acid derivative
09/05/2007EP1829860A1 9,10-secopregnane derivative and medicine
09/05/2007EP1829858A2 Dibenzylamine compounds and pharmaceutical use thereof
09/05/2007EP1829544A1 Pharmaceutically active morpholinol
09/05/2007EP1829542A1 Peroxisome proliferator-activated receptor (ppar) activator and drug, supplement, functional food and food additive using the same